Literature DB >> 10298666

Intervention strategies to improve adherence among hypertensives: review and recommendations.

K Glanz, T O Scholl.   

Abstract

Hypertension is a leading public health problem, which significantly increases the risks of death and disability from cardiovascular and cerebrovascular diseases. Medical treatment is effective for reducing hypertension and the associated risks, but nonadherence to recommendations for treatment has limited the realization of benefits of advances in medical care. This paper reviews recent attempts to improve adherence to medical regimens for the control of high blood pressure. Adherence to antihypertension regimens is defined as a behavioral problem, which includes a series of steps: participation in screening, entering treatment, continuing treatment, and adhering to the prescribed regimen. In the past decade, a wide range of structural and educational interventions attempting to increase adherence have had varying degrees of success. The interventions, their efficacy, study designs, and populations studied are reviewed, and recommendations for future testing and adoption of strategies for improving management of hypertension are advance.

Entities:  

Mesh:

Year:  1982        PMID: 10298666     DOI: 10.1016/s0738-3991(82)80031-1

Source DB:  PubMed          Journal:  Patient Couns Health Educ        ISSN: 0190-2040


  3 in total

1.  Contributions of public health to patient compliance.

Authors:  B K Rimer; K Glanz; C Lerman
Journal:  J Community Health       Date:  1991-08

2.  Validation of knowledge and adherence assessment tools among patients on warfarin therapy in a Saudi hospital anticoagulant clinic.

Authors:  Sireen Abdul Rahim Shilbayeh; Wejdan Ali Almutairi; Sarah Ahmed Alyahya; Nouf Hayef Alshammari; Eiad Shaheen; Alya Adam
Journal:  Int J Clin Pharm       Date:  2017-11-30

3.  Assessment of chronic illness care (ACIC): a practical tool to measure quality improvement.

Authors:  Amy E Bonomi; Edward H Wagner; Russell E Glasgow; Michael VonKorff
Journal:  Health Serv Res       Date:  2002-06       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.